| 000 | 01022 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250512051059.0 | ||
| 264 | 0 | _c19880708 | |
| 008 | 198807s 0 0 eng d | ||
| 022 | _a0003-911X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLenk, H | |
| 245 | 0 | 0 |
_aHuman pharmacological investigation of a human recombinant tumor necrosis factor preparation (PAC-4D) a phase-I trial. _h[electronic resource] |
| 260 |
_bArchiv fur Geschwulstforschung _c1988 |
||
| 300 |
_a89-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadverse effects |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xadverse effects |
| 700 | 1 | _aTanneberger, S | |
| 700 | 1 | _aMüller, U | |
| 700 | 1 | _aShiga, T | |
| 773 | 0 |
_tArchiv fur Geschwulstforschung _gvol. 58 _gno. 2 _gp. 89-97 |
|
| 999 |
_c3383382 _d3383382 |
||